MDRX — Veradigm Share News
0.000.00%
Last trade - 00:00HealthcareAdventurousMid Cap
- $555.85m
- $309.65m
- $588.02m
Brief: Veradigm Inc. Receives Nasdaq Notice Regarding Delayed Form 10-K Filing, Provides Update On 4Th Quarter And Full Fiscal Year 2022 Reporting Of Results
Veradigm Inc expected to post earnings of 27 cents a share - Earnings Preview
Veradigm Inc expected to post earnings of 27 cents a share - Earnings Preview
Brief: Veradigm Inc. Update On 4Th Quarter And Full Fiscal Year 2022 Reporting Of Results
Brief: Veradigm Inc Files Non-Timely 10-K With The U.S. SEC
Veradigm Inc expected to post earnings of 27 cents a share - Earnings Preview
Veradigm Inc expected to post earnings of 27 cents a share - Earnings Preview
Brief: Veradigm And HealthVerity Collaborate To Advance Evidence And Care For Cardiovascular Disease And Diabetes Patients
U.S. STOCKS ON THE MOVE-Levi Strauss, Salesforce, Eli Lilly
Veradigm jumps on $250 mln share repurchase program
Brief: Veradigm Announces New Share Repurchase Program And Initial Financial Guidance For Fiscal 2023
Brief: Veradigm Announces Strategic Investment In Holmusk
Brief: Allscripts Announces Corporate Name Change To Veradigm Inc.
Allscripts Healthcare Solutions Inc reports results for the quarter ended in September - Earnings Summary
Allscripts Healthcare Solutions Inc expected to post earnings of 19cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP-Adobe, Benefitfocus, Fedex
Brief: Allscripts Announces Second Quarter Of 2022 Results
Brief: Allscripts Announces First Quarter Of 2022 Results
Allscripts Healthcare Solutions Inc expected to post earnings of 21 cents a share - Earnings Preview